BUY Aurobindo Pharma — Rajesh Satpute, 13 Aug 2026

BUYAurobindo Pharma

Aurobindo Pharma share price target & all analyst calls

byRajesh SatputeHorizon: NA (inferred Intraday)13 Aug 2026, 9:25 am ISTvia CNBC Awaaz.

Entry₹1,671.6Inferred

Target₹1,720

Total upside +2.90%

Stop loss₹1,660-0.69% risk

Exit₹1,66013 Aug 2026, 1:54 pm

Stop-loss hit-0.69%

Follow Rajesh Satpute for new calls(8% target hit, 124 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 13 Aug 2026

6 supporting0 opposing

Supports the BUY call (6)

Aurobindo Pharma Expands Margins as Sales Grow

NewsGoogle News·12 Aug · today

4 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·12 Aug · yesterday

Results: Aurobindo Pharma Limited Exceeded Expectations And The Consensus Has Updated Its Estimates

NewsGoogle News·8 Aug · 5d ago

Aurobindo Pharma rises 3% after Q1 beat; HDFC Securities retains 'Add', Axis Securities cuts to 'Hold'

NewsGoogle News·7 Aug · 6d ago

Hold Aurobindo Pharma; target of Rs 1600: Prabhudas Lilladher

NewsGoogle News·7 Aug · 6d ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Rajesh Satpute

Every call and its outcome